WATSON PHARMACEUTICALS INC 4
4 · WATSON PHARMACEUTICALS INC · Filed Mar 2, 2005
Insider Transaction Report
Form 4
AMATO LYNNE
VP, Brand Sales & Operations
Transactions
- Exercise/Conversion
Common Stock, par value $0.0033
2005-02-28$21.25/sh+15,000$318,750→ 15,057 total - Sale
Common Stock, par value $0.0033
2005-02-28$31.82/sh−15,000$477,300→ 57 total - Exercise/Conversion
Incentive Stock Options to Purchase Common Stock
2005-02-28−15,000→ 0 totalExercise: $21.25From: 2002-06-23Exp: 2007-06-23→ Common Stock, par value $0.0033 (15,000 underlying)